Ensifentrine (RPL554): an inhaled "bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease / Cazzola, M; Page, C; Calzetta, L; Matera, Mg. - In: PHARMACEUTICAL PATENT ANALYST. - ISSN 2046-8954. - 7:6(2018), pp. 249-257. [10.4155/ppa-2018-0030]
Ensifentrine (RPL554): an inhaled "bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease
Calzetta L;
2018-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.